Boswelliaand Immune Support.
Evidence gradeA
ImpactModerate
Confidencehigh
Imported rating. This grade comes from SuppCo and has not been independently reviewed. It describes research, not a product, and it is not medical advice.
The rating
- Direction
- Favourable
- Rated by
- SuppCo
- Observed
- 28 September 2026
Studies behind it
Boswellic Acids Reduce Systemic Inflammation in Patients with Moderate COVID-19 Through Modulation of NF-κB Pathway.Sepideh Barzin Tond · Journal of dietary supplements2025Potential therapeutic effects of boswellic acids/Boswellia serrata extract in the prevention and therapy of type 2 diabetes and Alzheimer’s diseaseA. Gomaa · Naunyn-Schmiedeberg's Archives of Pharmacology2021Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases.H. Dureja · Endocrine, metabolic & immune disorders drug targets2023